Lipogems Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Lipogems General Information
Description
Developer of effective medical technologies designed to offer a compliant and reliable option for orthopedic issues. The company's system provides cushion and assistance for the healing process that contains a high concentration of reparative cells, does not decline with age and processing preserves the cell and tissue microarchitecture, enabling orthopedic physicians and scientists to reduce the risk of contamination through a simple and minimally invasive procedure.
Contact Information
Website
www.lipogems.comCorporate Office
- Viale Bianca Maria 24
- 20129 Milan(Lombardy)
- Italy
Corporate Office
- Viale Bianca Maria 24
- 20129 Milan(Lombardy)
- Italy
Lipogems Timeline
Lipogems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 05-Mar-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Nov-2024 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 23-Dec-2022 | $13.1M | $18.3M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 27-Jun-2022 | $5.19M | $5.19M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lipogems Patents
Lipogems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4422594-A1 | Microfragmented fat tissue as drug delivery system in liver cancer therapy | Pending | 26-Oct-2021 | ||
| US-20240415972-A1 | Microfragmented fat tissue as drug delivery system in liver cancer therapy | Pending | 26-Oct-2021 | ||
| WO-2023072755-A1 | Microfragmented fat tissue as drug delivery system in liver cancer therapy | Inactive | 26-Oct-2021 | ||
| EP-3612231-A1 | Drug delivery system | Active | 20-Apr-2017 | ||
| EP-3612231-B1 | Drug delivery system | Active | 20-Apr-2017 | A61K9/148 |
Lipogems Signals
Lipogems Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ABC Company | PE/Buyout | Minority | ||
| LIFTT | Venture Capital | Minority |
Lipogems FAQs
-
When was Lipogems founded?
Lipogems was founded in 2010.
-
Where is Lipogems headquartered?
Lipogems is headquartered in Milan, Italy.
-
What is the size of Lipogems?
Lipogems has 21 total employees.
-
What industry is Lipogems in?
Lipogems’s primary industry is Biotechnology.
-
Is Lipogems a private or public company?
Lipogems is a Private company.
-
What is Lipogems’s current revenue?
The current revenue for Lipogems is .
-
How much funding has Lipogems raised over time?
Lipogems has raised $26M.
-
Who are Lipogems’s investors?
ABC Company and LIFTT have invested in Lipogems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process